EHAB Enhabit, Inc.

NYSE Services-Home Health Care Services DE CIK: 0001803737
AI RATING
SELL
60% Confidence

Investment Thesis

Enhabit exhibits severe operational deterioration with net income collapsing 76.9% YoY despite flat revenue growth, signaling acute margin compression in its home health care business. Minimal returns on capital (ROE 3.5%, ROA 1.6%) combined with weakening interest coverage (2.6x) leave insufficient buffer for further earnings decline, while data quality concerns regarding gross margin reporting add uncertainty.

Strengths

  • + Operating cash flow of $35.2M exceeds reported net income, suggesting earnings quality resilience despite profitability decline
  • + Positive free cash flow generation of $32.7M (12.3% margin) provides near-term liquidity buffer
  • + Moderate leverage at 0.73x debt-to-equity and adequate current ratio of 1.56x

Risks

  • ! Catastrophic 76.9% YoY net income decline while revenue grew only 2.4% indicates structural margin compression
  • ! Abnormally high gross margin (157%) raises data quality concerns and obscures true cost structure visibility
  • ! Critically weak interest coverage of 2.6x with deteriorating profitability creates elevated default risk; limited operational cushion

Key Metrics to Watch

Financial Metrics

Revenue
264.8M
Net Income
19.2M
EPS (Diluted)
$0.36
Free Cash Flow
32.7M
Total Assets
1.2B
Cash
50.0M

Profitability Ratios

Gross Margin 157.0%
Operating Margin 11.1%
Net Margin 7.3%
ROE 3.5%
ROA 1.6%
FCF Margin 12.3%

Balance Sheet & Liquidity

Current Ratio
1.56x
Quick Ratio
1.56x
Debt/Equity
0.73x
Debt/Assets
50.5%
Interest Coverage
2.64x
Long-term Debt
402.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-08T10:05:06.305268 | Data as of: 2026-03-31 | Powered by Claude AI